Skip to Content

BRX 0.25 (Rexulti 0.25 mg)

Generic Name: brexpiprazole

Pill with imprint BRX 0.25 is Brown, Round and has been identified as Rexulti 0.25 mg. It is supplied by Otsuka Pharmaceutical Co., Ltd. and Lundbeck.

Rexulti is used in the treatment of major depressive disorder; schizophrenia; depression and belongs to the drug class atypical antipsychotics. Rexulti 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BRX 0.25

Rexulti 0.25 mg BRX 0.25

Rexulti

Generic Name:
brexpiprazole
Imprint:
BRX 0.25
Strength:
0.25 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Atypical antipsychotics
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Otsuka Pharmaceutical Co., Ltd. and Lundbeck
National Drug Code (NDC):
59148-0035

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide